Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FXYD3 |
| Upstream (Parents) |
|---|
| (<<) GALNT3 → FXYD3 |
| (<<) CEACAM5 → FXYD3 |
| Downstream (Children) |
|---|
| FXYD3 → TYRP1 (>>) |
| FXYD3 → GALNT6 (>>) |
| FXYD3 → SLC9A2 (>>) |
| FXYD3 → EML3 (>>) |
| FXYD3 → QPCT (>>) |
| FXYD3 → PPARG (>>) |
| FXYD3 → GDPD3 (>>) |
| FXYD3 → PTPRR (>>) |
| FXYD3 → TFF3 (>>) |
| FXYD3 → MUC1 (>>) |
| FXYD3 → TSPAN1 (>>) |
| FXYD3 → KLF4 (>>) |
| FXYD3 → PADI2 (>>) |
| FXYD3 → SPINK5 (>>) |
| FXYD3 → PTGES (>>) |
